Cellebrite DI Ltd (NASDAQ:CLBT) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET
Company Participants
Andrew Kramer - VP, IR
Yossi Carmil - Founder, CEO & Director
Dana Gerner - CFO
Conference Call Participants
Michael Cikos - Needham & Company
Jonathan Ho - William Blair & Company
Jeff Van Rhee - Craig-Hallum
Hugh Cunningham - TD Cowen
Tal Liani - Bank of America Merrill Lynch
Jamie Shelton - Deutsche Bank
Douglas Bruehl - JPMorgan Chase & Co.
Operator
Welcome to the Cellebrite Third Quarter 2023 Financial Results Conference Call. [Operator Instructions].
I would now like to turn the call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours.
Andrew Kramer
Thank you very much, Todd. Welcome to Cellebrite's third quarter 2023 financial results conference call.
Joining me today from just outside of Washington, D.C. are Yossi Carmil, Cellebrite CEO and Dana Gerner, Cellebrite CFO. There's a slide presentation that accompanies our prepared remarks. Please advance the slides in the webcast viewer to follow our commentary. We will call out the slide number we're referring to in our remarks. This call is being recorded and a replay of this recording will be made available on our website shortly after the call.
Let's start on Slide #2, a copy of today's press release and financial statements, including the GAAP, non-GAAP reconciliations. The slide presentation and the quarterly financial tables and supplemental financial information for the third quarter '23 and each quarter of 2022 and 2021 are available on the investor relations website at investors.cellebrite.com.
Also unless stated otherwise, our discussion of our third quarter 2023 financial metrics as well as the financial metrics provided in our outlook on today's conference call will be done on a non-GAAP basis only and all historical comparisons are with the third quarter of 2022, unless otherwise noted.
In addition, please note that the statements made during this call that are not statements of historical facts constitute forward-looking statements. All forward looking statements are subject to risks and uncertainties and other factors that could cause matters expressed or implied by those forward-looking statements not to occur. They could also cause the actual results to differ materially from historical results and/or from the forecasts.
Some of these forward-looking statements are discussed under the heading, Risk Factors and elsewhere in the company's annual report on Form 20-F filed with the SEC on April 27, 2023. The company does not undertake to update any forward-looking statements to reflect future events or circumstances.